Predicting local control of brain metastases after Gamma Knife radiosurgery: a multimodal deep learning-radiomics approach.

Authors

Minghui Zhao, Xiaofeng Ding, Xinchen Sun, Qun Chen, Jindong Li

Published in

BMC medical imaging. Jul 18, 2026. Epub Jul 18, 2026.

Abstract

Accurate prediction of local control (LC) following Gamma Knife radiosurgery (GKRS) remains clinically challenging for patients with brain metastases (BMs) secondary to breast or lung cancer. The scarcity of validated pre-therapeutic biomarkers currently hinders the development of individualized treatment decision-making strategies.
This retrospective analysis included 324 BMs from 195 patients. To develop and benchmark various predictive frameworks, several models were constructed: clinical-only, radiomics-only, 2D deep learning (DL)-only, fused radiomics-DL (DLR), and a Combined model integrating all three modalities (clinical, radiomic, and DL features). All imaging signatures were derived from pre-treatment contrast-enhanced T1-weighted (T1CE) magnetic resonance imaging (MRI). Model performance was evaluated using the area under the curve (AUC), calibration plots, the Hosmer-Lemeshow test, and decision curve analysis (DCA).
The Combined model demonstrated consistently high numerical discriminative performance, achieving an AUC of 0.854 (95% Confidence Interval [CI]: 0.791-0.917) in the training cohort and 0.781 (95% CI: 0.618-0.945) in the independent test cohort. DCA demonstrated that the Combined model yielded superior net clinical benefit across threshold probabilities ranging from 10% to 50%, outperforming all other candidate models. Consequently, a nomogram based on the Combined model was developed to facilitate individualized risk estimation.
The integration of clinical parameters, handcrafted radiomic features, and 2D deep learning signatures provides a robust predictive tool for LC following GKRS in patients with brain metastases from breast or lung cancer. This multimodal approach holds significant potential for refining post-radiosurgical management and advancing personalized neuro-oncology care.

PMID:
42471553
Bibliographic data and abstract were imported from PubMed on 19 Jul 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.